Phase II

2

Review clinical trials related to Phase II. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms

To learn if imetelstat can help to control MDS/MPNs.

Participants needed: 30
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Apr 24, 2026Locations: 1
Eligibility criteria

Age ≥18 years as MF and CMML are very rare diseases in the pediatric population. [+16]

Participants who are currently receiving treatment for a malignancy (not includi... [+8]

Status: Not yet recruiting

Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma

To learn if sacituzumab tirumotecan can help to control advanced or metastatic SMARCB1-deficient RMC in patients whose disease has progressed after receiving at least 1 treatment.

Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Mar 2, 2026Locations: 1
Eligibility criteria

Participants with locally advanced or metastatic RMC histologically confirmed by... [+18]

Participants must not have any other malignancies within the past 2 years except... [+24]